Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedFeb 06, 2025
DataAggregated Company Financials
Companies8
  • 7D4.4%
  • 3M9.5%
  • 1Y19.2%
  • YTD12.5%

Roche Holding is up 2.0%, leading the way for the Pharma industry, which has gained 2.6%. This takes the industry's 12 month performance to a gain of 16%. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 06 Feb 2025CHF 468.6bCHF 122.5bCHF 19.1b23x24.5x3.8x
Sat, 04 Jan 2025CHF 429.0bCHF 119.6bCHF 21.4b17.9x20x3.6x
Mon, 02 Dec 2024CHF 435.0bCHF 117.8bCHF 21.1b18.6x20.6x3.7x
Wed, 30 Oct 2024CHF 457.1bCHF 116.9bCHF 20.9b19.9x21.8x3.9x
Fri, 27 Sep 2024CHF 454.7bCHF 114.6bCHF 19.3b21.8x23.6x4x
Sun, 25 Aug 2024CHF 472.1bCHF 114.7bCHF 19.3b22.5x24.5x4.1x
Tue, 23 Jul 2024CHF 457.4bCHF 116.9bCHF 20.6b32.7x22.2x3.9x
Thu, 20 Jun 2024CHF 430.5bCHF 115.5bCHF 19.6b33.9x21.9x3.7x
Sat, 18 May 2024CHF 417.8bCHF 113.3bCHF 19.9b40.3x21x3.7x
Mon, 15 Apr 2024CHF 400.4bCHF 112.6bCHF 19.5b36.7x20.5x3.6x
Wed, 13 Mar 2024CHF 391.9bCHF 110.2bCHF 19.7b23.8x19.9x3.6x
Fri, 09 Feb 2024CHF 376.9bCHF 110.0bCHF 19.6b24x19.2x3.4x
Sun, 07 Jan 2024CHF 412.8bCHF 119.3bCHF 18.6b26.8x22.2x3.5x
Tue, 05 Dec 2023CHF 397.9bCHF 120.7bCHF 18.8b24.9x21.1x3.3x
Thu, 02 Nov 2023CHF 383.5bCHF 123.1bCHF 19.2b23.6x20x3.1x
Sat, 30 Sep 2023CHF 407.6bCHF 113.6bCHF 18.2b44.5x22.4x3.6x
Mon, 28 Aug 2023CHF 405.7bCHF 112.0bCHF 17.9b47.7x22.6x3.6x
Wed, 26 Jul 2023CHF 419.8bCHF 114.2bCHF 19.2b37.8x21.9x3.7x
Fri, 23 Jun 2023CHF 422.1bCHF 115.2bCHF 18.9b37.6x22.4x3.7x
Sun, 21 May 2023CHF 434.9bCHF 115.3bCHF 18.9b39.9x23x3.8x
Tue, 18 Apr 2023CHF 436.3bCHF 115.0bCHF 18.8b42.3x23.2x3.8x
Thu, 16 Mar 2023CHF 385.4bCHF 116.6bCHF 19.1b25.6x20.2x3.3x
Sat, 11 Feb 2023CHF 407.7bCHF 116.2bCHF 19.0b29.1x21.4x3.5x
Mon, 09 Jan 2023CHF 438.3bCHF 117.3bCHF 34.7b22.5x12.6x3.7x
Wed, 07 Dec 2022CHF 447.4bCHF 117.9bCHF 34.9b23.2x12.8x3.8x
Fri, 04 Nov 2022CHF 462.3bCHF 121.0bCHF 36.3b23.4x12.7x3.8x
Sun, 02 Oct 2022CHF 443.3bCHF 120.6bCHF 37.0b20.2x12x3.7x
Tue, 30 Aug 2022CHF 445.3bCHF 120.0bCHF 36.7b21.1x12.1x3.7x
Thu, 28 Jul 2022CHF 461.1bCHF 119.7bCHF 36.6b28x12.6x3.9x
Sat, 25 Jun 2022CHF 446.7bCHF 118.3bCHF 37.2b26.8x12x3.8x
Mon, 23 May 2022CHF 461.9bCHF 119.4bCHF 37.7b29.2x12.3x3.9x
Wed, 20 Apr 2022CHF 511.9bCHF 117.9bCHF 36.9b32.9x13.9x4.3x
Fri, 18 Mar 2022CHF 483.8bCHF 117.2bCHF 36.5b20.7x13.3x4.1x
Sun, 13 Feb 2022CHF 453.9bCHF 116.6bCHF 36.3b18.7x12.5x3.9x
Price to Earnings Ratio

12.5x


Total Market Cap: CHF 453.9bTotal Earnings: CHF 36.3bTotal Revenue: CHF 116.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 18.7x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 24.4x which is higher than its 3-year average PE of 18.7x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 19% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market0.13%
Healthcare3.60%
Pharma4.41%
Pharma4.41%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 97.714.2%
+CHF 5.5b		11.1%PE17.9x
ROG Roche HoldingCHF 287.700.9%
+CHF 2.0b		27.9%PE27.6x
GALD Galderma GroupCHF 118.544.3%
+CHF 1.2b		n/aPS7.2x
SDZ Sandoz GroupCHF 44.081.7%
+CHF 320.3m		57.3%PS2.1x
NWRN Newron PharmaceuticalsCHF 10.107.2%
+CHF 13.6m		15.6%PS30.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ROG

CHF 287.70

Roche Holding

7D

0.9%

1Y

27.9%

Roche Holding's (VTX:ROG) Soft Earnings Are Actually Better Than They Appear

Feb 05
Roche Holding's (VTX:ROG) Soft Earnings Are Actually Better Than They Appear

NOVN

CHF 97.71

Novartis

7D

4.2%

1Y

11.1%

Novartis (VTX:NOVN) Is Increasing Its Dividend To $3.50

Feb 04
Novartis (VTX:NOVN) Is Increasing Its Dividend To $3.50

SDZ

CHF 44.08

Sandoz Group

7D

1.7%

1Y

57.3%

GALD

CHF 118.54

Galderma Group

7D

4.3%

1Y

n/a

DESN

CHF 213.00

Dottikon ES Holding

7D

-3.4%

1Y

-8.4%

COPN

CHF 63.80

Cosmo Pharmaceuticals

7D

-3.0%

1Y

1.1%

Weekly Picks: NLBR’s vision, MNSO’s expansion plans and COPN’s opportunity

Jan 23
Weekly Picks: NLBR’s vision, MNSO’s expansion plans and COPN’s opportunity

NWRN

CHF 10.10

Newron Pharmaceuticals

7D

7.2%

1Y

15.6%

ADXN

CHF 0.06

Addex Therapeutics

7D

-4.1%

1Y

-17.8%